Thermo Fisher boosts sequencing business with $13.6B Life Tech buy

Thermo Fisher Scientific agreed to acquire Life Technologies, a maker of laboratory equipment for the life sciences, for $13.6 billion. The acquisition, which is expected to be finalized early next year, would make Thermo Fisher a major player in the next-generation gene sequencing market. The deal also improves "all three elements of our growth strategy: technological innovation, a unique customer value proposition, and expansion in emerging markets," Thermo Fisher President and CEO Marc Casper said.

View Full Article in:

GenomeWeb Daily News (free registration) · American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX